Drug Safety Update - November 2022
The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for November 2022 (PDF).
This issue invites clinicians to respond to a consultation that will influence how the MHRA communicate with healthcare professionals in the future.
This issue contains the latest COVID-19 vaccine and medicine information including information on newly licensed vaccines and updated product information.
Lastly in this issue is a summary of letters to healthcare professionals in October. These generally related to supply issues and recalls.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
| « Antiviral Medicines Authorised for Influenza Season 2022/23 | CKS Updates - November 2022 » |
Leave a Comment